The US Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as…
Invimeds HealthNovember 2, 2023
Tyruko (natalizumab-site), a natalizumab biosimilar, has been authorized by the FDA as…
Invimeds HealthSeptember 8, 2023
Another wreath has been added to Horizon Therapeutics' pre-takeover victory lap. Months…
Invimeds HealthSeptember 1, 2023
FDA has recently approved the first-ever treatment for pancreatitis, a protein-loss form…
Invimeds HealthAugust 31, 2023
A prominent role player in the pharmaceutical and healthcare industry, InviMeds Health…
Invimeds HealthAugust 31, 2023
InviMeds Health a leading healthcare company is proud to announce its successful…
Invimeds HealthAugust 30, 2023